» Articles » PMID: 34080069

Diagnostic Methods and Therapeutic Options of Uveal Melanoma with Emphasis on MR Imaging-Part I: MR Imaging with Pathologic Correlation and Technical Considerations

Abstract

Uveal melanoma is a malignant neoplasm that derives from pigmented melanocytes of the uvea and involves, in order of decreasing prevalence, the choroid, ciliary body and iris. Its prognosis is related to histopathologic and genetic features, tumor size and location, extraocular extension. The diagnosis is fundamentally based on clinical evaluation (ophthalmoscopy, biomicroscopy) and ultrasonography. MRI is useful in case of untransparent lens or subretinal effusion. Moreover, MRI has a significant role to confirm the diagnosis, in the evaluation of the local extent of the disease with implications for treatment planning, and in the follow-up after radiotherapy treatment. Uveal melanoma can show different morphologic features (lentiform, dome or mushroom shape) and often determines retinal detachment. MR appearance of uveal melanoma mainly depends on the melanin content. Uveal melanoma typically displays high signal intensity on T1-weighted images and low signal intensity on T2-weighted images. Nevertheless, imaging appearance may be variable based on the degree of pigmentation and the presence of areas of necrosis or cavitation. Differential diagnosis includes other uveal lesions. The radiologists and in particular MRI play a significant role in the clinical management of uveal melanoma. The purpose of this pictorial review is to provide the radiologists with awareness about diagnostic methods and therapeutic options of uveal melanoma. In the present first section we summarize the MR anatomy of the eye and describe ophthalmological and radiological imaging techniques to diagnose uveal melanomas, with emphasis on the role of MR imaging. Additionally, we review MR imaging appearance of uveal melanomas.

Citing Articles

Dynamic Contrast-Enhanced Magnetic Resonance Imaging Findings and the Relevance of Histopathological Findings in Intraocular Solitary Fibrous Tumors.

Koga M, Ideguchi R, Kono R, Yoshikawa A, Toya R Cureus. 2025; 17(1):e77299.

PMID: 39935925 PMC: 11810680. DOI: 10.7759/cureus.77299.


Proton Radiation Therapy: A Systematic Review of Treatment-Related Side Effects and Toxicities.

Salem P, Chami P, Daou R, Hajj J, Lin H, Chhabra A Int J Mol Sci. 2024; 25(20.

PMID: 39456752 PMC: 11506991. DOI: 10.3390/ijms252010969.


Clinical Implications of Ultrasound-Based Morphology in Choroidal Melanoma.

Ramos-Davila E, Dalvin L Ophthalmol Retina. 2024; 9(3):263-271.

PMID: 39326547 PMC: 11885033. DOI: 10.1016/j.oret.2024.09.010.


Quantitative Perfusion-Weighted Magnetic Resonance Imaging in Uveal Melanoma.

Klaassen L, Jaarsma-Coes M, Marinkovic M, Luyten G, Rasch C, Ferreira T Invest Ophthalmol Vis Sci. 2024; 65(11):17.

PMID: 39250118 PMC: 11385876. DOI: 10.1167/iovs.65.11.17.


A cuproptosis-related prognostic signature for guiding clinical diagnosis and treatment in uveal melanoma patients.

Yang Y, Li Q, Chen J, Guo Y, Cai Y, Zhao W Heliyon. 2024; 10(16):e36324.

PMID: 39247274 PMC: 11378888. DOI: 10.1016/j.heliyon.2024.e36324.


References
1.
Wei W, Mo J, Jie Y, Li B . Adenoma of the retinal pigment epithelium: a report of 3 cases. Can J Ophthalmol. 2010; 45(2):166-70. DOI: 10.3129/i09-249. View

2.
Foti P, Farina R, Coronella M, Palmucci S, Montana A, Sigona A . Diffusion-weighted magnetic resonance imaging for predicting and detecting the response of ocular melanoma to proton beam therapy: initial results. Radiol Med. 2015; 120(6):526-35. DOI: 10.1007/s11547-014-0488-7. View

3.
Finger P, Chin K, Iacob C . 18-Fluorine-labelled 2-deoxy-2-fluoro-D-glucose positron emission tomography/computed tomography standardised uptake values: a non-invasive biomarker for the risk of metastasis from choroidal melanoma. Br J Ophthalmol. 2006; 90(10):1263-6. PMC: 1857459. DOI: 10.1136/bjo.2006.097949. View

4.
Andreoli M, Mieler W, Leiderman Y . Epidemiological trends in uveal melanoma. Br J Ophthalmol. 2015; 99(11):1550-3. DOI: 10.1136/bjophthalmol-2015-306810. View

5.
Decatur C, Ong E, Garg N, Anbunathan H, Bowcock A, Field M . Driver Mutations in Uveal Melanoma: Associations With Gene Expression Profile and Patient Outcomes. JAMA Ophthalmol. 2016; 134(7):728-33. PMC: 4966162. DOI: 10.1001/jamaophthalmol.2016.0903. View